TRIM29: A Potential Drug Target and Biomarker (G23650)

Target Name: TRIM29

NCBI ID: G23650

TRIM29

TRIM29: A Potential Drug Target and Biomarker

TRIM29, short for Tripartite motif containing 29, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure, consisting of three RNA domains joined together, has led to a great deal of interest in its function and potential as a drug target.

TRIM29 is a key regulator of gene expression in various organisms, including humans. It has been shown to play a role in the regulation of stem cell proliferation and differentiation, immune cell function, and tissue repair. Its functions have been attributed to its ability to interact with various protein molecules, including transcription factors, to regulate their activity and determine the expression of target genes.

One of the most promising aspects of TRIM29 is its potential as a drug target. Its unique structure and the various functions it has been shown to play make it an attractive target for small molecules. Many studies have demonstrated the potential of small molecules to modulate TRIM29's activity and trigger its downstream targets. These small molecules have the potential to be used for a variety of therapeutic applications, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, TRIM29 has also been identified as a potential biomarker. Its expression has been shown to be regulated in a variety of tissues and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. By using TRIM29 as a biomarker, researchers may be able to monitor the effectiveness of therapeutic interventions and determine the course of disease.

The search for TRIM29's functions has been an ongoing process, and its potential as a drug target and biomarker continues to grow. Many researchers are now focusing on the development of small molecules that can modulate TRIM29's activity and determine its role in various biological processes. As more research is conducted, it is likely that we will gain a better understanding of TRIM29's functions and its potential as a drug target and biomarker.

In conclusion, TRIM29 is a non-coding RNA molecule that has shown to play a critical role in various biological processes. Its unique structure and the various functions it has been shown to play make it an attractive target for small molecules. As more research is conducted, its potential as a drug target and biomarker will continue to grow, and we can look forward to the development of new therapeutic applications for TRIM29 and its derivatives.

Protein Name: Tripartite Motif Containing 29

Functions: Plays a crucial role in the regulation of macrophage activation in response to viral or bacterial infections within the respiratory tract. Mechanistically, TRIM29 interacts with IKBKG/NEMO in the lysosome where it induces its 'Lys-48' ubiquitination and subsequent degradation. In turn, the expression of type I interferons and the production of pro-inflammatory cytokines are inhibited. Additionally, induces the 'Lys-48' ubiquitination of STING1 in a similar way, leading to its degradation

The "TRIM29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets